Mylan Says $107M Verdict Should Stand In Generic Paxil Fight

By Alex Wolf (February 24, 2015, 11:02 PM EST) -- Mylan Inc. urged the Third Circuit on Monday to uphold a $106.7 million jury verdict against GlaxoSmithKline PLC, saying there was sufficient evidence for its claims that GSK breached an exclusivity agreement through an antitrust settlement that allowed Apotex Inc. to sell generic Paxil....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!